Kezar Life Sciences, Inc. (KZR)

NASDAQ: KZR · Real-Time Price · USD

4.350

+0.080 (1.87%)

At close: Jun 27, 2025, 4:00 PM

4.440

+0.090 (2.07%)

After-hours: Jun 27, 2025, 4:04 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023
Period Ending	Dec '23 Dec 31, 2023
Immune-mediated Diseases and Cancer Therapeutics	7.00M

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023
Period Ending	Dec '23 Dec 31, 2023
United States	7.00M